ModelEdge

Regeneron Pharmaceuticals, Inc.
REGN
Filing Type10-K
Filing Date2/4/2025
Updated2/5/25, 7:18 AM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2023
EX-4.1DESCRIPTION OF SECURITIES
EX-10.8 1AMENDMENT AGREEMENT, DATED DECEMBER 30, 2014 BETWEEN BAYER AND REGISTRANT
EX-19.1INSIDER TRADING POLICY
EX-21.1SUBSIDIARIES OF THE REGISTRANT
EX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLP
EX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
GRAPHIC
GRAPHIC